The criteria of the Italian Federation of Thrombosis Centres on DOACs: a “real world” application in nonvalvular atrial fibrillation patients already on Vitamin K Antagonist

Ensuring medication adherence with direct oral anticoagulant drugs

(2014) Alessandro Di Minno et al.   THROMBOSIS RESEARCH

Dabigatran: how the drug company withheld important analyses

(2014) D. Cohen   BMJ-British Medical Journal

Concerns over data in key dabigatran trial

(2014) D. Cohen   BMJ-British Medical Journal

The trouble with dabigatran

(2014) B. Charlton et al.   BMJ-British Medical Journal

Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: Proposals of the Working Group on Perioperative Haemostasis (GIHP) – March 2013

(2013) Gilles Pernod et al.   Archives of Cardiovascular Diseases

The laboratory and the direct oral anticoagulants

(2013) A. Tripodi   BLOOD

Combination of a new oral anticoagulant, aspirin and clopidogrel after acute coronary syndrome: new therapeutic standard?

(2013) Andrea Rubboli et al.   Internal and Emergency Medicine

Perioperative management of patients who are receiving a novel oral anticoagulant

(2013) Aaron Liew et al.   Internal and Emergency Medicine

Telemedicine can improve the quality of oral anticoagulation using portable devices and self-testing at home

(2013) Doris Barcellona et al.   JOURNAL OF TELEMEDICINE AND TELECARE

The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients

(2013) Paul A. Reilly et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

(2013) Robert P. Giugliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPEAN HEART JOURNAL

Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation

(2012) Mark J Alberts et al.   LANCET NEUROLOGY

What did we learn from new oral anticoagulant treatment?

(2012) Charles T. Esmon   THROMBOSIS RESEARCH

Questions and answers on the use of dabigatran and perpectives on the use of other new oral anticoagulants in patients with atrial fibrillation.

(2011) Luciano Crippa et al.   THROMBOSIS AND HAEMOSTASIS

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

(2010) Lars Wallentin et al.   LANCET

Medication Adherence

(2009) P. Michael Ho et al.   CIRCULATION